Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase–Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)
Saved in:
| Title: | Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase–Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2) |
|---|---|
| Authors: | Stewart, Adam G1,2 (AUTHOR), Paterson, David L1,2 (AUTHOR), Young, Barnaby3,4,5 (AUTHOR), Lye, David C3,4,5,6 (AUTHOR), Davis, Joshua S7,8 (AUTHOR), Schneider, Kellie7 (AUTHOR), Yilmaz, Mesut9 (AUTHOR), Dinleyici, Rumeysa9 (AUTHOR), Runnegar, Naomi10 (AUTHOR), Henderson, Andrew1,10 (AUTHOR), Archuleta, Sophia6,11 (AUTHOR), Kalimuddin, Shirin12,13 (AUTHOR), Forde, Brian M1,14,15 (AUTHOR), Chatfield, Mark D1 (AUTHOR), Bauer, Michelle J1 (AUTHOR), Lipman, Jeffrey1,16,17 (AUTHOR), Harris-Brown, Tiffany1 (AUTHOR), Harris, Patrick N A1,18 (AUTHOR) p.harris@uq.edu.au, (ASID-CRN), MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (AUTHOR) |
| Source: | Open Forum Infectious Diseases. Aug2021, Vol. 8 Issue 8, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 23288957 |
|---|---|
| DOI: | 10.1093/ofid/ofab387 |
